Top

Gepubliceerd in:

01-08-2014 | Original Article

Medication Adherence and HIV Symptom Distress in Relation to Panic Disorder Among HIV-Positive Adults Managing Opioid Dependence

Auteurs: Jesse D. Kosiba, Adam Gonzalez, Conall O’Cleirigh, Steven A. Safren

Gepubliceerd in: Cognitive Therapy and Research | Uitgave 4/2014

Abstract

Panic disorder (PD) occurs at greater rates among those with HIV compared to those without HIV. Rates of PD may be elevated among those with opioid dependence (persons who inject drugs, PWID). Persons with HIV experience common bodily symptoms as a result of the disease and these symptoms overlap with those of PD which may contribute to a “fear of fear” cycle present in PD. HIV-positive, PWID represent an at-risk population in terms of poor medication adherence. HIV symptoms and HIV medication side-effects commonly overlap with panic symptoms and may affect HIV medication adherence. The aim of this investigation was to examine the impact of PD on HIV-related symptom distress and HIV medication adherence in HIV-positive adults (N = 131) in treatment for opioid use. Those with a diagnosis of PD evidenced greater levels of HIV symptom distress and lower levels of medication adherence than those without current PD. Results highlight the clinical importance of assessing for and treating PD among individuals with HIV that are prescribed antiretroviral therapy. Future work would benefit from examining observed associations longitudinally and identifying potential mechanisms involved.

vorige artikel Contamination Aversion and Posttraumatic Stress Symptom Severity Following Sexual Trauma

volgende artikel The Moderating Role of Experiential Avoidance in the Prospective Relationship Between Anxiety Sensitivity and Anxiety

Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet, 376, 367–387. doi:10.1016/S0140-6736(10)60829-X.PubMedCrossRef

Barlow, D. H. (2002). Anxiety and its disorders (2nd ed.). New York, NY: Guilford.

Barrera, T. L., & Norton, P. J. (2009). Quality of life impairment in generalized anxiety disorder, social phobia, and panic disorder. Journal of Anxiety Disorders, 23, 1086–1090. doi:10.1016/j.janxdis.2009.07.011.PubMedCentralPubMedCrossRef

Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., et al. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58, 721–728.PubMedCrossRef

Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., et al. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365, 493–505. doi:10.1056/NEJMoa1105243.PubMedCentralPubMedCrossRef

Del Romero, J., Castilla, J., Hernando, V., Rodriguez, C., & Garcia, S. (2010). Combined antiretroviral treatment and heterosexual transmission of HIV-1: Cross sectional and prospective cohort study. BMJ, 340, c2205. doi:10.1136/bmj.c2205.PubMedCentralPubMedCrossRef

Donnell, D., Baeten, J. M., Kiarie, J., Thomas, K. K., Stevens, W., Cohen, C. R., et al. (2010). Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. Lancet, 375, 2092–2098. doi:10.1016/S0140-6736(10)60705-2.

Ehlers, A. (1995). A 1-year prospective study of panic attacks: Clinical course and factors associated with maintenance. Journal of Abnormal Psychology, 104, 164–172.PubMedCrossRef

Emamzadeh-Fard, S., Fard, S. E., SeyedAlinaghi, S., & Paydary, K. (2012). Adherence to anti-retroviral therapy and its determinants in HIV/AIDS patients: A review. Infectious Disorders: Drug Targets, 12, 346–356.CrossRef

Fisher, J. D., Smith, L. R., & Lenz, E. M. (2010). Secondary prevention of HIV in the United States: Past, current, and future perspectives. Journal of Acquired Immune Deficiency Syndromes, 55(Suppl 2), S106–S115. doi:10.1097/QAI.0b013e3181fbca2f.PubMedCentralPubMedCrossRef

Gadermann, A. M., Alonso, J., Vilagut, G., Zaslavsky, A. M., & Kessler, R. C. (2012). Comorbidity and disease burden in the National Comorbidity Survey Replication (NCS-R). Depression and Anxiety, 29, 797–806. doi:10.1002/da.21924.PubMedCentralPubMedCrossRef

Garcia de Olalla, P., Knobel, H., Carmona, A., Guelar, A., Lopez-Colomes, J. L., & Cayla, J. A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 30, 105–110.PubMedCrossRef

Gardner, E. M., Sharma, S., Peng, G., Hullsiek, K. H., Burman, W. J., Macarthur, R. D., et al. (2008). Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS, 22, 75–82. doi:10.1097/QAD.0b013e3282f366ff.PubMedCentralPubMedCrossRef

Gay, C., Portillo, C. J., Kelly, R., Coggins, T., Davis, H., Aouizerat, B. E., et al. (2011). Self-reported medication adherence and symptom experience in adults with HIV. Journal of the Association of Nurses in AIDS Care, 22, 257–268. doi:10.1016/j.jana.2010.11.004.PubMedCentralPubMedCrossRef

Gonzalez, A., Barinas, J., & O’Cleirigh, C. (2011a). Substance use: Impact on adherence and HIV medical treatment. Current HIV/AIDS Reports, 8, 223–234. doi:10.1007/s11904-011-0093-5.PubMedCrossRef

Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011b). Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 58, 181–187. doi:10.1097/QAI.0b013e31822d490a.PubMed

Gonzalez, A., Mimiaga, M. J., Israel, J., Bedoya, A., & Safren, S. A. (2013). Substance use predictors of poor medication adherence: The role of substance use coping among HIV-infected patients in opioid dependence treatment. AIDS and Behavior, 17, 168–173. doi:10.1007/s10461-012-0319-6.PubMedCentralPubMedCrossRef

Gonzalez, A., Zvolensky, M. J., Parent, J., Grover, K. W., & Hickey, M. (2012). HIV symptom distress and anxiety sensitivity in relation to panic, social anxiety, and depression symptoms among HIV-positive adults. AIDS Patient Care and STDS, 26, 156–164. doi:10.1089/apc.2011.0309.PubMedCrossRef

Goodwin, R. D., & Eaton, W. W. (2003). Asthma and the risk of panic attacks among adults in the community. Psychological Medicine, 33, 879–885.PubMedCrossRef

Grant, B. F., Hasin, D. S., Chou, S. P., Stinson, F. S., & Dawson, D. A. (2004). Nicotine dependence and psychiatric disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 61, 1107–1115. doi:10.1001/archpsyc.61.11.1107.PubMedCrossRef

Gros, D. F., Milanak, M. E., Brady, K. T., & Back, S. E. (2013). Frequency and severity of comorbid mood and anxiety disorders in prescription opioid dependence. American Journal on Addictions, 22, 261–265. doi:10.1111/j.1521-0391.2012.12008.x.PubMedCrossRef

Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., et al. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS, 18(Suppl 1), S19–S25.PubMedCentralPubMedCrossRef

Ickovics, J. R., Hamburger, M. E., Vlahov, D., Schoenbaum, E. E., Schuman, P., Boland, R. J., et al. (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. JAMA, 285, 1466–1474.PubMedCrossRef

Justice, A. C., Chang, C. H., Rabeneck, L., & Zackin, R. (2001). Clinical importance of provider-reported HIV symptoms compared with patient-report. Medical Care, 39, 397–408.PubMedCrossRef

Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005a). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 593–602. doi:10.1001/archpsyc.62.6.593.PubMedCrossRef

Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005b). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617–627. doi:10.1001/archpsyc.62.6.617.PubMedCentralPubMedCrossRef

Kessler, R. C., Chiu, W. T., Jin, R., Ruscio, A. M., Shear, K., & Walters, E. E. (2006). The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Archives of General Psychiatry, 63, 415–424. doi:10.1001/archpsyc.63.4.415.PubMedCentralPubMedCrossRef

Kuritzkes, D. R. (2004). Preventing and managing antiretroviral drug resistance. AIDS Patient Care and STDS, 18, 259–273. doi:10.1089/108729104323076007.PubMedCrossRef

Lejuez, C. W., Paulson, A., Daughters, S. B., Bornovalova, M. A., & Zvolensky, M. J. (2006). The association between heroin use and anxiety sensitivity among inner-city individuals in residential drug use treatment. Behaviour Research Therapy, 44, 667–677. doi:10.1016/j.brat.2005.04.006.

Leserman, J. (2008). Role of depression, stress, and trauma in HIV disease progression. Psychosomatic Medicine, 70, 539–545. doi:10.1097/PSY.0b013e3181777a5f.PubMedCrossRef

Liu, H., Miller, L. G., Hays, R. D., Wagner, G., Golin, C. E., Hu, W., et al. (2006). A practical method to calibrate self-reported adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 43(Suppl 1), S104–S112. doi:10.1097/01.qai.0000245888.97003.a3.PubMedCrossRef

Low-Beer, S., Yip, B., O’Shaughnessy, M. V., Hogg, R. S., & Montaner, J. S. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndromes, 23, 360–361.PubMedCrossRef

Marc, L. G., Wang, M. M., & Testa, M. A. (2012). Psychometric evaluation of the HIV symptom distress scale. AIDS Care, 24, 1432–1441. doi:10.1080/09540121.2012.656567.PubMedCentralPubMedCrossRef

Martins, S. S., Keyes, K. M., Storr, C. L., Zhu, H., & Chilcoat, H. D. (2009). Pathways between nonmedical opioid use/dependence and psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence, 103, 16–24. doi:10.1016/j.drugalcdep.2009.01.019.PubMedCentralPubMedCrossRef

Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMedCrossRef

Puskas, C. M., Forrest, J. I., Parashar, S., Salters, K. A., Cescon, A. M., Kaida, A., et al. (2011). Women and vulnerability to HAART non-adherence: A literature review of treatment adherence by gender from 2000 to 2011. Current HIV/AIDS Reports, 8, 277–287. doi:10.1007/s11904-011-0098-0.PubMedCrossRef

Safren, S. A., O’Cleirigh, C. M., Bullis, J. R., Otto, M. W., Stein, M. D., & Pollack, M. H. (2012). Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 80, 404–415. doi:10.1037/a0028208.PubMedCentralPubMedCrossRef

Safren, S. A., O’Cleirigh, C., Tan, J. Y., Raminani, S. R., Reilly, L. C., Otto, M. W., et al. (2009). A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychology, 28, 1–10. doi:10.1037/a0012715.PubMedCentralPubMedCrossRef

Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl 20), 22–33. (quiz 34–57).PubMed

Smitherman, T. A., Kolivas, E. D., & Bailey, J. R. (2013). Panic disorder and migraine: Comorbidity, mechanisms, and clinical implications. Headache, 53, 23–45. doi:10.1111/head.12004.PubMedCrossRef

Stirratt, M. J., Remien, R. H., Smith, A., Copeland, O. Q., Dolezal, C., Krieger, D., et al. (2006). The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS and Behavior, 10, 483–493. doi:10.1007/s10461-006-9106-6.PubMedCrossRef

Tsao, J. C., Dobalian, A., & Naliboff, B. D. (2004). Panic disorder and pain in a national sample of persons living with HIV. Pain, 109, 172–180. doi:10.1016/j.pain.2004.02.001.PubMedCrossRef

Tucker, J. S., Burnam, M. A., Sherbourne, C. D., Kung, F. Y., & Gifford, A. L. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. American Journal of Medicine, 114, 573–580.PubMedCrossRef

Turner, B. J., Laine, C., Cosler, L., & Hauck, W. W. (2003). Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. Journal of General Internal Medicine, 18, 248–257.PubMedCentralPubMedCrossRef

Von Korff, M., Crane, P., Lane, M., Miglioretti, D. L., Simon, G., Saunders, K., et al. (2005). Chronic spinal pain and physical–mental comorbidity in the United States: Results from the national comorbidity survey replication. Pain, 113, 331–339. doi:10.1016/j.pain.2004.11.010.CrossRef

Willgoss, T. G., & Yohannes, A. M. (2013). Anxiety disorders in patients with COPD: A systematic review. Respiratory Care, 58, 858–866. doi:10.4187/respcare.01862.PubMed

Zogg, J. B., Woods, S. P., Sauceda, J. A., Wiebe, J. S., & Simoni, J. M. (2012). The role of prospective memory in medication adherence: A review of an emerging literature. Journal of Behavioral Medicine, 35, 47–62. doi:10.1007/s10865-011-9341-9.PubMedCentralPubMedCrossRef

Titel: Medication Adherence and HIV Symptom Distress in Relation to Panic Disorder Among HIV-Positive Adults Managing Opioid Dependence
Auteurs: Jesse D. Kosiba
Adam Gonzalez
Conall O’Cleirigh
Steven A. Safren
Publicatiedatum: 01-08-2014
Uitgeverij: Springer US
Gepubliceerd in: Cognitive Therapy and Research / Uitgave 4/2014
Print ISSN: 0147-5916
Elektronisch ISSN: 1573-2819
DOI: https://doi.org/10.1007/s10608-014-9608-x

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 4/2014

The Influence of Body Dissatisfaction on Set Shifting Ability

The Short-Term Impact of a Paranoid Explanation on Self-esteem: An Experimental Study

Emotion Regulation of Goals in Bipolar Disorder and Major Depression: A Comparison of Rumination and Mindfulness

The Moderating Role of Experiential Avoidance in the Prospective Relationship Between Anxiety Sensitivity and Anxiety

Development and Validation of the GI-Cognitions Questionnaire

Decentering Mediates the Effect of Ruminative and Experiential Self-Focus on Negative Thinking in Depression